Synapse - Find an Expert

1253 Results

Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin

Journal Article

Horwitz, S. M.; Advani, R. H.; Bartlett, N. L.; Jacobsen, E. D.; Sharman, J. P.; O'Connor, O. A.; Siddiqi, T.; Kennedy, D. A.; Oki, Y.
Blood (2014)

Fulltext@MSK | Save

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: Insights from BOLERO-2

Journal Article

Rugo, H. S.; Pritchard, K. I.; Gnant, M.; Noguchi, S.; Piccart, M.; Hortobagyi, G.; Baselga, J.; Perez, A.; Geberth, M.; Csoszi, T.; more...
Annals of Oncology (2014)

Fulltext@MSK | Save

Results of an open-label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and Sézary syndrome

Journal Article

Querfeld, C.; Rosen, S. T.; Guitart, J.; Duvic, M.; Kim, Y. H.; Dusza, S. W.; Kuzel, T. M.
Blood (2014)

Fulltext@MSK | Save

Phase II trial of patupilone in patients with brain metastases from breast cancer

Journal Article

Peereboom, D. M.; Murphy, C.; Ahluwalia, M. S.; Conlin, A.; Eichler, A.; Van Poznak, C.; Baar, J.; Elson, P.; Seidman, A. D.
Neuro-Oncology (2014)

Fulltext@MSK | Save

B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins

Journal Article

Ng, P. P.; Kuo, C. C.; Wang, S.; Einav, S.; Arcaini, L.; Paulli, M.; Portlock, C. S.; Marcotrigiano, J.; Tarr, A.; Ball, J.; more...
Blood (2014)

Fulltext@MSK | Save

Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: An open-label, randomised phase 3 trial

Journal Article

Motzer, R. J.; Porta, C.; Vogelzang, N. J.; Sternberg, C. N.; Szczylik, C.; Zolnierek, J.; Kollmannsberger, C.; Rha, S. Y.; Bjarnason, G. A.; Melichar, B.; more...
Lancet Oncology (2014)

Fulltext@MSK | Save

Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion spect-based imaging agent (99mtc-etarfolatide)

Journal Article

Morris, R. T.; Joyrich, R. N.; Naumann, R. W.; Shah, N. P.; Maurer, A. H.; Strauss, H. W.; Uszler, J. M.; Symanowski, J. T.; Ellis, P. R.; Harb, W. A.
Annals of Oncology (2014)

Fulltext@MSK | Save

Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): Extended follow-up of a phase 3, randomised, open-label study